Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in now. Johnson & Johnson (NYSE:JNJ) announced on ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally ...

The biggest names in cardiology tech gathered in New Orleans for the American College of Cardiology (ACC) Scientific Sessions ...

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

A combination of left ventricular support plus delayed percutaneous coronary intervention did not reduce infarct size compared with immediate PCI in patients with anterior STEMI without shock, ...

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...

Using ex vivo machine perfusion - maintaining organs outside the body on a perfusion system - a novel platform was developed to enable genetic engineering of whole tissues prior to transplantation.

Northwestern Medicine investigators have uncovered a missing link behind the harmful effects of autoantibodies linked to ...